Recent Updates
Recently added Catalysts
SRPT Positive Sentiment

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting

Thursday, September 24, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Sarepta Therapeutics will present new data from its neuromuscular portfolio at the 27th Annual Neuromuscular Study Group Scientific Meeting in San Antonio, Texas, from September 25-27, 2026. The presentation will include seven posters, featuring the first results from the Phase 4 ENDURE Study, which focuses on patients receiving delandistrogene moxeparvov.

Market Sentiment Analysis

POSITIVE FACTORS

  • Sarepta is leading in precision genetic medicine for rare diseases.
  • The presentation at a significant scientific meeting highlights ongoing research.
  • New data from the Phase 4 ENDURE Study is being shared.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+46%
120-day peak, hindsight
Typical move
10.9%
average across 7 past catalysts
Lead asset
SRP-9003
Phase 3 · Limb Girdle Muscular Dystrophy

Full Press Release Details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present new data at the 27th Annual Neuromuscular Study Group (NMSG) Scientific Meeting, taking place Sept. 25-27, 2026, in San Antonio, Texas. Sarepta will present seven posters at NMSG. Among the analyses are the first results from the Phase 4 ENDURE Study, a multi-center, prospective, observational study in patients receiving delandistrogene moxeparvov

Frequently Asked Questions

What is the NMSG Scientific Meeting?

The NMSG Scientific Meeting is an annual event focused on neuromuscular research.

When will Sarepta present its new data?

Sarepta will present its new data from September 25-27, 2026.

What study results will Sarepta present?

Sarepta will present results from the Phase 4 ENDURE Study.

Where is the NMSG Meeting being held?

The NMSG Meeting will take place in San Antonio, Texas.

ShareAdd on Google
Tags: SRPT Viatris Investor Conferences Healthcare Sarepta Therapeutics NMSG Meeting Phase 4 ENDURE Study delandistrogene moxeparvov neuromuscular portfolio
Last updated: Sep 24, 2026

Biotech snapshot

Cash runway
$788M liquidity · $0M/mo burn
Low dilution risk
Lead asset
SRP-9003Phase 3
Limb Girdle Muscular Dystrophy →

Catalyst track record

+46%
best trade around SRPT's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for SRPT.

See every catalyst's timing & PoA →